Isis appoints chief business officer
This article was originally published in Scrip
Isis Pharmaceuticals has named Sarah Boyce chief business officer. In this newly created position, Ms Boyce will provide strategic leadership from a commercial background and lead Isis' corporate development activities. Prior to joining California-based Isis, Ms Boyce was vice-president, head of international business strategy and operations at Forest Laboratories.
You may also be interested in...
Diversity in all forms is critical to innovation in health care, says AstraZeneca’s chief medical officer, Ann Taylor. In an exclusive interview, she talks about the company’s work in mentoring and education, and why tackling issues around diversity and inclusion must be driven by the C-suite alongside community initiatives.
A selection of articles you might have missed from October 2020, including exclusive interviews with industry leaders and a deeper dive into the Femtech market.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.